Three months ago, federal health officials announced that the government plans to ban a potent opioid. Health Secretary Robert F. Kennedy II called the substance “endangering the lives of Americans.” This substance is a highly addictive compound extracted from the cardamom leaf. Pain is a plant produced in Southeast Asia. Its powder and tincture are sold in convenience stores and e-cigarette stores all over the United States, and are promoted as refreshing and pain relieving products. Officials said at the time that implementing the ban was essential “to avoid imminent public safety risks.” This month, there was a reversal in the government's attitude. Kennedy announced on October 9 that its competent authorities “followed scientific findings” and decided to allow the retention of a certain amount of the compound. This policy reversal stems from the fact that in recent months, many card pain product companies have detected this substance in their products that they claim to be “natural.” The head of a major pain distribution company launched an intensive lobbying campaign after facing multiple lawsuits against him and evidence that the compound was detected in related products surfaced.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.